Major expectations from Pharma 2030 Strategy in Russia 2019

One half of respondents in Russia stated they expected the development and introduction of new medicines and pharmaceutical goods on the market from the Pharma 2030 Strategy, according to a survey from June 2019. Furthermore, almost 30 percent of the polled foresaw a decrease in imports of medical goods to Russia and an increase of local production.

根据2019年6月的一项调查，俄罗斯受访者中有一半表示，他们期望从2030年制药战略中看到新药品和医药产品的开发和市场引入。此外，近30%的受访者预测，俄罗斯医疗用品的进口将减少，而本地生产将增加。